The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays
Jonathan S. Duke‐Cohan(Harvard University), Ellis L. Reinherz(Harvard University), Kristin Wollenick(Dana-Farber Cancer Institute), Elizabeth Witten(Dana-Farber Cancer Institute), Michael S. Seaman(Beth Israel Deaconess Medical Center), Lindsey R. Baden(Brigham and Women's Hospital), Raphael Dolin(Beth Israel Deaconess Medical Center)
Cited by 27
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969